2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theSustained Release Excipients Market?

As chronic and acute illnesses become increasingly prevalent, the sustained-release excipients market is expected to witness significant growth. Chronic illnesses are medical conditions that endure for a prolonged period, usually three months or longer, while acute diseases are identified by a swift onset of severe but short-lived symptoms. These conditions may develop abruptly and are normally short-term, lasting anywhere from several hours to a few days or weeks. Sustained-release excipients have a wide range of applications in the pharmaceutical product formulation for both types of diseases. This is because they enhance patient compliance, maintain stable drug levels, minimize side effects, and improve disease management, thus driving the sales of sustained-release excipients. For example, cardiovascular diseases recorded the highest number of NCD deaths as per the World Health Organization (WHO), a Switzerland-based specialized health agency, in September 2022, affecting approximately 17.9 million people annually. This was closely followed by deaths from chronic respiratory diseases (4.1 million), diabetes (2.0 million), and cancer (9.3 million). Furthermore, a report published by the American College of Cardiology in August 2022 predicted increased prevalence of all four major cardiovascular risk factors across the US from 2025 to 2060. According to these projections, diabetes is expected to see the biggest surge, with a 39.3% increase to 55 million cases. This will be followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The report also predicted considerable increases in stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), as well as ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) cases. As such, the rising prevalence of chronic and acute diseases is a significant driving factor for the growth of the sustained-release excipients market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

#What Long-Term Growth Rate is Expected for theSustained Release Excipients Market Between 2025 and 2034?

The market size of sustained release excipients has significantly expanded in the past few years. The market is projected to rise from $1.4 billion in 2024 to $1.53 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the previous years include elevated demand for controlled drug release, the widespread of chronic illnesses, compliance and convenience for patients, innovative developments in the pharmaceutical sector, and regulatory backing for extended-release formulations.

The market size for sustained release excipients is projected to experience significant growth in the coming years, climbing to $2.13 billion in 2029 with a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period can be credited to factors such as the rising number of elderly individuals, the emphasis on individualized medicine, challenges concerning patient compliance, the increase in complex drug formulations, advancements in managing diseases, and the expansion of global healthcare. Noteworthy trends during this forecast period comprise patient-focused drug delivery, partnerships for the development of formulations, regulatory compliance and safety, global growth of drug formulation technologies, and the impact of biopharmaceuticals.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10822

Which Upcoming Market Trends and Innovations Are Set to Influence theSustained Release Excipients Market’s Path Forward?

The prevailing trend of product innovation is becoming increasingly popular within the sustained release excipients market. Major players in this market are focusing on the creation of inventive products to solidify their market standing. For example, Nutriventia Limited, a pharmaceutical company based in India, introduced Prolanza, an advanced ashwagandha ingredient (Withania somnifera) in September 2022, which is a sustained-release product. Prolanza, a pure ashwagandha root extract, provides enduring stress reduction support. It offers extended therapeutic effects with a unique release mechanism, requiring just a single daily dosage. Comparative studies showed that Prolanza ashwagandha had superior absorption, enhanced bioavailability, and extended elimination half-life than its control counterpart, indicating a sustained-release pattern. Given ashwagandha’s primary use of adapting to and reducing stress responses, Prolanza’s therapeutic effects promise to be more enduring and positively impact overall health. It’s a natural herb-based product clinically proven to be effective.

Who Are the Dominant Market Players Pushing the Boundaries of theSustained Release Excipients Market?

Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Frères, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefossé SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

#thebusinessresearchcompany #marketresearch #marketintelligence

The sustained release excipients market covered in this report is segmented –

1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan

2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration

3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

Subsegments:

1) By Gelatin: Type A Gelatin, Type B Gelatin

2) By Polymers: Natural Polymers, Synthetic Polymers

3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients

4) By Sugars: Sucrose, Lactose, Glucose, Other Sugars

5) By Alcohol: Ethanol, Isopropyl Alcohol, Other Alcohols

6) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10822&type=smp

What Regions Are Dominating the Sustained Release Excipients Market Growth?

North America was the largest region in the global sustained release excipients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Sustained Release Excipients Maret 2025, By The Business Research Company:

Animal Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Nanomedicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Pharmaceutical Excipients Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: